↓ Skip to main content

Phase II trial of the histone deacetylase inhibitor vorinostat (Zolinza™, suberoylanilide hydroxamic acid, SAHA) in patients with recurrent and/or metastatic head and neck cancer

Overview of attention for article published in Investigational New Drugs, October 2007
Altmetric Badge

Mentioned by

patent
2 patents

Citations

dimensions_citation
150 Dimensions

Readers on

mendeley
68 Mendeley